SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

 Division of Renal-Electrolyte

[Return To Index page]
photo Linda Fried, MD, MPH

Professor of Medicine

Associate Professor of Epidemiology

Chief, Peritoneal Dialysis, VA Pittsburgh Healthcare System

Staff Physician, VA Pittsburgh Healthcare System

Email: lff9@pitt.edu

Phone: 412-360-3930

Contact
Office: 7E121 VA Pittsburgh Healthcare System
University Drive Center
Pittsburgh, PA 15240
 
Phone: 412-360-3930
Fax: 412-360-6908
E-mail: lff9@pitt.edu
Education and Training
Education
BS, Cornell University, 1986
M.D., Mount Sinai School of Medicine, 1990
M.P.H., Univ. of Pittsburgh Graduate School of Public Health, 1998
Training
Internal Medicine Intern and Resident, Columbia Presbyterian Medical Center, 1993
Nephrology Fellowship, University of Pittsburgh School of Medicine, 1996
Research Interest
Dr. Fried’s research has concentrated in two areas: The association of decreased kidney function with adverse outcomes in older individuals, including cardiovascular disease, functional decline and change in body composition. My other research interest is progression of kidney disease, in particular diabetic nephropathy. I chaired, VA NEPHRON D, a VA sponsored multi-center study on combination ACEI/ARB on progression of diabetic nephropathy. I am currently chair of the Steering Committee for the NIDDK CKD Pilot Study consortium.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O’Connor, T., Palevsky, P. M., Reilly, R. F., Seliger, S. L., Warren, S. R., Watnick, S., Peduzzi, P., Guarino, P., for the VA NEPHRON-D Investigators. Combined angiotensin inhibition for treatment of diabetic nephropathy. New England Journal of Medicine. 2013; 369(20): 1892-903.
Yenchek, R. H., Ix, J. H., Shlipak, M. G., Bauer, D. C., Rianon, N.J., Kritchevsky, S.B., Harris, T. B., Newman, A. B., Cauley, J. A., Fried, L. F., for the Health ABC Study. Bone Mineral Density and Fracture Risk in Older Individuals with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2012; 7(7): 1030-6.
Fried, L. F., Lee, J. S., Shlipak, M., Chertow, G. M., Green, C., Ding J, Harris T,, Newman AB, for the Health ABC Study. Chronic kidney disease and functional limitation in the elderly: The Health, Aging and Body Composition Study. Journal of the American Geriatrics Society. 2006; 54(5): 750-6.
Fried, L.F., Katz, R., Sarnak, M. J., Shlipak, M. G., Chaves, P. H. M., Jenny, N.S., Stehman-Breen, C., Gillen, D., Bleyer, A. J., Hirsh, C., Siscovick, D., Newman, A. B. Kidney function as a predictor of non-cardiovascular mortality. Journal of the American Society of Nephrology. 2005; 16(12): 3728-35.
Shlipak, M.G., Sarnak, M.J., Katz, R., Fried, L.F., Seliger, S.L., Newman, A.B., Siscovick, D.S., Stehman-Breen, C. Cystatin-C and risk of death and cardiovascular disease in the elderly. New England Journal of Medicine. 2005; 352(20): 2049-60.
Fried, L., Orchard, T., Kasiske, B. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney International. 2001; 59(1): 260-9.
Sponsored Research/Activities
Title: CKD Pilot Trials - Chair
Role: Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Start Year: 2015
End Year: 2016
Title: The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes
Role: Co-Investigator
Funding Agency: National Institute on Alcohol Abuse & Alcoholism
Grant Number: R01 AG027002
Start Year: 2012
End Year: 2016
Title: The Aging Kidney: Chronic Injury, Impaired Functions and Clinical Outcomes
Role: Co-Investigator
Funding Agency: New England Medical Center/National Institute of Aging
Grant Number: R01 AG027002
Start Year: 2011
End Year: 2016
Title: BEACON (Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events
Role: Co-Investigator
Funding Agency: Reata Pharmaceuticals
Grant Number: 402-C-0903
Start Year: 2011
End Year: 2013